Physiomics (PYC) Competitors GBX 0.41 -0.01 (-2.38%) As of 08:33 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock PYC vs. MTFB, GENF, BSFA, DEST, ROQ, VAL, RENE, SALV, NFX, and ONCShould you be buying Physiomics stock or one of its competitors? The main competitors of Physiomics include Motif Bio (MTFB), Genflow Biosciences (GENF), BSF Enterprise (BSFA), Destiny Pharma (DEST), Roquefort Therapeutics (ROQ), ValiRx (VAL), ReNeuron Group (RENE), SalvaRx Group (SALV), Nuformix (NFX), and Oncimmune (ONC). These companies are all part of the "biotechnology" industry. Physiomics vs. Motif Bio Genflow Biosciences BSF Enterprise Destiny Pharma Roquefort Therapeutics ValiRx ReNeuron Group SalvaRx Group Nuformix Oncimmune Physiomics (LON:PYC) and Motif Bio (LON:MTFB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, community ranking, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Is PYC or MTFB more profitable? Motif Bio has a net margin of 0.00% compared to Physiomics' net margin of -106.80%. Motif Bio's return on equity of 0.00% beat Physiomics' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-106.80% -127.68% -76.38% Motif Bio N/A N/A N/A Does the MarketBeat Community believe in PYC or MTFB? Motif Bio received 289 more outperform votes than Physiomics when rated by MarketBeat users. Likewise, 74.40% of users gave Motif Bio an outperform vote while only 55.56% of users gave Physiomics an outperform vote. CompanyUnderperformOutperformPhysiomicsOutperform Votes8055.56% Underperform Votes6444.44% Motif BioOutperform Votes36974.40% Underperform Votes12725.60% Does the media refer more to PYC or MTFB? In the previous week, Physiomics' average media sentiment score of 0.00 equaled Motif Bio'saverage media sentiment score. Company Overall Sentiment Physiomics Neutral Motif Bio Neutral Which has better earnings and valuation, PYC or MTFB? Motif Bio has lower revenue, but higher earnings than Physiomics. Physiomics is trading at a lower price-to-earnings ratio than Motif Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£864.07K0.97-£922.82K-£0.45-0.92Motif BioN/AN/AN/A-£19.20N/A SummaryMotif Bio beats Physiomics on 6 of the 8 factors compared between the two stocks. Get Physiomics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYC vs. The Competition Export to ExcelMetricPhysiomicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£841,000.00£128.97M£5.33B£2.62BDividend Yield6.20%3.74%5.20%5.05%P/E Ratio-0.923.4226.72134.60Price / Sales0.974,168.72395.56221,328.11Price / Cash4.2113.1938.3228.03Price / Book1.9733.216.763.84Net Income-£922,817.80-£91.56M£3.23B£5.88B7 Day Performance-1.91%3.50%0.41%3.54%1 Month Performance1.99%7.75%9.12%25.38%1 Year Performance-69.96%102.80%18.73%130.62% Physiomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYCPhysiomicsN/AGBX 0.41-2.4%N/A-70.1%£841,000.00£864,071.75-0.9210Gap DownMTFBMotif BioN/AN/AN/AN/A£3.28MN/A-0.036GENFGenflow BiosciencesN/AGBX 0.85-5.6%N/A-59.7%£2.90M£-226,187.99-1.605Gap UpBSFABSF EnterpriseN/AGBX 2.33+15.1%N/A-55.2%£2.87M£80,250.74-1.4112Gap UpDESTDestiny PharmaN/AN/AN/AN/A£2.87M£135,028.00-50.0024Gap DownHigh Trading VolumeROQRoquefort TherapeuticsN/AGBX 1.59-3.8%N/A-66.2%£2.02M£2,662.35-1.319Gap DownVALValiRxN/AGBX 0.51-7.1%N/A-81.5%£1.94M£27,777.32-0.345,450Gap DownRENEReNeuron GroupN/AN/AN/AN/A£1.93M£783,000.00-37.502Gap DownSALVSalvaRx GroupN/AN/AN/AN/A£1.65M£64.50M0.032Gap UpNFXNuformix1.7515 of 5 starsGBX 0.12-3.3%GBX 293+252,486.2%-56.2%£1.43MN/A-3.523News CoverageGap UpONCOncimmuneN/AN/AN/AN/A£1.29M£1.86M0.1352 Related Companies and Tools Related Companies Motif Bio Competitors Genflow Biosciences Competitors BSF Enterprise Competitors Destiny Pharma Competitors Roquefort Therapeutics Competitors ValiRx Competitors ReNeuron Group Competitors SalvaRx Group Competitors Nuformix Competitors Oncimmune Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PYC) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PYC Stock Free PYC Stock Alerts